Trials / Unknown
UnknownNCT03102359
Brain Protection Effect of Selective Head Cooling and Dexmedetomidine in Patients Undergoing Liver Transplantation
Cerebral Protection Effect of Selective Head Cooling and Dexmedetomidine in Patients Undergoing Liver Transplantation
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Huazhong University of Science and Technology · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The investigators investigated in the present study whether selective head cooling and dexmedetomidine has an effect on cerebral oxygenation during liver transplantation and has cerebral protective effect in patients undergoing liver transplantation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexmedetomidine | Using dexmedetomidine at anesthesia induction and maintain until the end of the surgery |
| DEVICE | Cooling Helmet | Using cooling helmet for selective head cooling group and Selective Head Cooling and Dexmedetomidine group |
Timeline
- Start date
- 2017-04-05
- Primary completion
- 2019-12-31
- Completion
- 2019-12-31
- First posted
- 2017-04-05
- Last updated
- 2019-05-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03102359. Inclusion in this directory is not an endorsement.